NUREG-1537, Part 2 - NRC

CHAPTER I
the applicant discussed in the SAR how the normal operating use and malfunctions
of the licensed facility could affect the other facilities. The reviewer should also
assess the discussion in the SAR of the effect of the shared facilities on the safety
of the subject facility. The reviewer may need to review discussions and analyses
in other sections of the SAR.
Evaluation Findings
This section of the SAR should contain sufficient information to support the
following types of conclusions, considering that most of the conclusions in this
section summarize the analysis and findings of other parts of the staffss safety
evaluation report:
* The shared facilities are clearly and completely listed and the other users
are identified. The applicant has shown that a malfunction or a loss of
function of these shared facilities would not affect the operation of the nonpower
reactor, nor would it damage the non-power reactor or its capability
to be safely shut down.
* Either normal operation or a loss of function of the shared facilities would
not lead to uncontrolled release of radioactive material from the licensed
facility to unrestricted areas, or in the event of release, the exposures are
analyzed in Chapter 13, "Accident Analyses," and are found to be
acceptable.
1.5 Comparison With Similar Facilities
Areas of Review
Since the early 1940s, several hundred non-power reactors have been built in the
United States, and many more were built in other countries. The first few such
reactors established the safety considerations and principles for the non-power
reactors that followed.
Several non-power reactors not licensed by NRC were used as early prototypes or
to develop fuels or other components. Examples of prototype or developmental
test facilities, whose results were adopted by licensed facilities, include the
following:
* bulk shielding facility (B SF)
* materials testing reactor (MTR)
* special power excursion reactor test (SPERT)
* Chicago Pile #5 or Argonne research reactor (CP-5)
NUREG-1537,PART2 1-8 REV 0,2/96
NUREG- 1 537, PART 2 1-8 REV 0, 2/96